These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism. Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399 [TBL] [Abstract][Full Text] [Related]
4. Nociceptive behavior induced by poly-L-lysine and other basic compounds involves the spinal NMDA receptors. Tan-No K; Esashi A; Nakagawasai O; Niijima F; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Tadano T Brain Res; 2004 May; 1008(1):49-53. PubMed ID: 15081381 [TBL] [Abstract][Full Text] [Related]
5. Intrathecal high-dose histamine induces spinally-mediated nociceptive behavioral responses through a polyamine site of NMDA receptors. Watanabe C; Orito T; Watanabe H; Mizoguchi H; Yonezawa A; Yanai K; Mobarakeh JI; Onodera K; Sakurada T; Sakurada S Eur J Pharmacol; 2008 Feb; 581(1-2):54-63. PubMed ID: 18155693 [TBL] [Abstract][Full Text] [Related]
6. Involvement of substance P and excitatory amino acids in aversive behavior elicited by intrathecal capsaicin. Okano K; Kuraishi Y; Satoh M Neurosci Res; 1994 Mar; 19(2):125-30. PubMed ID: 7516512 [TBL] [Abstract][Full Text] [Related]
7. Intrathecal co-administration of NMDA antagonist and NK-1 antagonist reduces MAC of isoflurane in rats. Ishizaki K; Sasaki M; Karasawa S; Obata H; Nara T; Goto F Acta Anaesthesiol Scand; 1999 Aug; 43(7):753-9. PubMed ID: 10456816 [TBL] [Abstract][Full Text] [Related]
8. Involvement of spinal NK2 and NMDA receptors in aversive behavior induced by intra-arterial injection of capsaicin. Ando R; Watanabe C; Kawamura S; Yonezawa A; Sakurada T Pharmacol Biochem Behav; 2001 Jan; 68(1):105-13. PubMed ID: 11274715 [TBL] [Abstract][Full Text] [Related]
9. Involvement of NMDA receptor in nociceptive effects elicited by intrathecal [Tyr6] gamma2-MSH(6-12), and the interaction with nociceptin/orphanin FQ in pain modulation in mice. Chang M; Li W; Peng YL; Gao YH; Yao J; Han RW; Wang R Brain Res; 2009 May; 1271():36-48. PubMed ID: 19332041 [TBL] [Abstract][Full Text] [Related]
10. Interaction among NMDA receptor-, NMDA glycine site- and AMPA receptor antagonists in spinally mediated analgesia. Nishiyama T Can J Anaesth; 2000 Jul; 47(7):693-8. PubMed ID: 10930211 [TBL] [Abstract][Full Text] [Related]
11. Spinal antinociception evoked by the triterpene 3beta, 6beta, 16beta-trihydroxylup-20(29)-ene in mice: evidence for the involvement of the glutamatergic system via NMDA and metabotropic glutamate receptors. Longhi-Balbinot DT; Pietrovski EF; Gadotti VM; Martins DF; Facundo VA; Santos AR Eur J Pharmacol; 2009 Nov; 623(1-3):30-6. PubMed ID: 19765585 [TBL] [Abstract][Full Text] [Related]
12. Involvement of spinal substance P and excitatory amino acids in inflammatory hyperalgesia in rats. Okano K; Kuraishi Y; Satoh M Jpn J Pharmacol; 1998 Jan; 76(1):15-22. PubMed ID: 9517400 [TBL] [Abstract][Full Text] [Related]
13. NMDA or non-NMDA receptor antagonists attenuate increased Fos expression in spinal dorsal horn GABAergic neurons after intradermal injection of capsaicin in rats. Zou X; Lin Q; Willis WD Neuroscience; 2001; 106(1):171-82. PubMed ID: 11564427 [TBL] [Abstract][Full Text] [Related]
14. NMDA receptor involvement in neuroplastic changes induced by neonatal capsaicin treatment in trigeminal nociceptive neurons. Chiang CY; Hu JW; Sessle BJ J Neurophysiol; 1997 Nov; 78(5):2799-803. PubMed ID: 9356428 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of NMDA and group I mGluR antagonists on both nociception and spinal cord protein kinase C translocation in the formalin test and a model of neuropathic pain in rats. Yashpal K; Fisher K; Chabot JG; Coderre TJ Pain; 2001 Oct; 94(1):17-29. PubMed ID: 11576741 [TBL] [Abstract][Full Text] [Related]
16. Intrathecally administered D-cycloserine produces nociceptive behavior through the activation of N-methyl-D-aspartate receptor ion-channel complex acting on the glycine recognition site. Tan-No K; Esashi A; Nakagawasai O; Niijima F; Furuta S; Sato T; Satoh S; Yasuhara H; Tadano T J Pharmacol Sci; 2007 May; 104(1):39-45. PubMed ID: 17452810 [TBL] [Abstract][Full Text] [Related]
17. Potentiation of a behavioural response in mice by spinal coadministration of substance P and excitatory amino acid agonists. Mjellem-Joly N; Lund A; Berge OG; Hole K Neurosci Lett; 1991 Nov; 133(1):121-4. PubMed ID: 1724310 [TBL] [Abstract][Full Text] [Related]
18. The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats. Ren K; Williams GM; Hylden JL; Ruda MA; Dubner R Eur J Pharmacol; 1992 Aug; 219(2):235-43. PubMed ID: 1358641 [TBL] [Abstract][Full Text] [Related]
19. Intrathecal non-NMDA excitatory amino acid receptor antagonists inhibit pain behaviors in a rat model of postoperative pain. Zahn PK; Umali E; Brennan TJ Pain; 1998 Feb; 74(2-3):213-23. PubMed ID: 9520236 [TBL] [Abstract][Full Text] [Related]
20. Stimulus intensity, cell excitation and the N-methyl-D-aspartate receptor component of sensory responses in the rat spinal cord in vivo. Chizh BA; Cumberbatch MJ; Herrero JF; Stirk GC; Headley PM Neuroscience; 1997 Sep; 80(1):251-65. PubMed ID: 9252236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]